Jan 17 (Reuters) - TRANSGENE SA:
* ‍FIRST CHRONIC HEPATITIS B PATIENT DOSED IN CHINA IN A PHASE 1 TRIAL OF T101​
* ‍FIRST DATA READOUT FROM STUDY IS EXPECTED AT BEGINNING OF 2019​
* ‍TRIAL WILL INCLUDE UP TO 36 PATIENTS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
 